Metastatic Type II Papillary Renal Cell Carcinoma With Recurrent Complete Responses to Sunitinib: A Case Report With a Literature Review

被引:1
|
作者
Al Ashour, Bayan H. [1 ]
Azam, Faisal [2 ]
Ibnshamsah, Fahad [2 ,3 ]
Alrowais, Fahad [4 ]
Al -Garni, Ayed [5 ]
Al-Shamsi, Humaid O. [6 ,7 ,8 ]
Bukhari, Nedal [2 ,3 ]
机构
[1] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dammam, Saudi Arabia
[2] King Fahad Specialist Hosp, Dept Med Oncol, Dammam, Saudi Arabia
[3] Imam Abdulrahman Bin Faisal Univ, Dept Internal Med, Dammam, Saudi Arabia
[4] King Fahad Specialist Hosp, Dept Radiat Oncol, Dammam, Saudi Arabia
[5] King Fahad Specialist Hosp, Dept Pathol & Lab Med, Dammam, Saudi Arabia
[6] Emirates Oncol Soc, Depatment Oncol, Dubai, U Arab Emirates
[7] Burjeel Canc Inst, Dept Oncol, Abu Dhabi, U Arab Emirates
[8] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates
关键词
complete response; sunitinib; tyrosine kinase inhibitors; papillary; renal cell carcinoma;
D O I
10.7759/cureus.25541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Papillary renal cell carcinoma (PRCC) is a less common subtype of kidney cancer and is typically more resistant to systemic treatments. This report describes a patient with metastatic type II PRCC who experienced two complete responses (CR) to the tyrosine kinase inhibitor (TKI) sunitinib. The patient remains on sunitinib with durable control of the disease. To the best of our knowledge, this is the first case of metastatic type II PRCC with CR to sunitinib.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Durable complete responses and near complete responses to sunitinib in metastatic renal cell carcinoma
    Heng, D. Y.
    Rini, B. I.
    Garcia, J.
    Wood, L.
    Bukowski, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Sunitinib rechallenge with dose escalation in progressive metastatic renal cell carcinoma A case report and literature review
    Zhang, Xingming
    Shen, Pengfei
    Yao, Jin
    Chen, Ni
    Liu, Jiyan
    Zeng, Hao
    MEDICINE, 2018, 97 (31)
  • [3] Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature
    Kaldrymides, Ph.
    Kostoglou-Athanassiou, I.
    Gkountouvas, A.
    Veniou, E.
    Ziras, N.
    ENDOCRINE, 2010, 37 (01) : 6 - 10
  • [4] Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature
    Ph. Kaldrymides
    I. Kostoglou-Athanassiou
    A. Gkountouvas
    E. Veniou
    N. Ziras
    Endocrine, 2010, 37 : 6 - 10
  • [5] Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma
    Heng, Daniel Y. C.
    Rini, Brian I.
    Garcia, Jorge
    Wood, Laura
    Bukowsk, Ronald M.
    CLINICAL GENITOURINARY CANCER, 2007, 5 (07) : 446 - 451
  • [6] Clear cell papillary renal cell carcinoma: a case report and literature review
    Patel, Simmi
    Asarian, Armand
    Xiao, Philip
    JOURNAL OF SURGICAL CASE REPORTS, 2019, (06):
  • [7] Primary extrarenal papillary type II renal cell carcinoma presenting as a pelvic mass: a case report and review of the literature
    Sarafi, Aikaterini
    Tasis, Nikolaos
    Mpalampou, Eleni
    Igoumenidi, Maria
    Arkoumani, Evdokia
    Tzovaras, Alexandros
    Korkolis, Dimitrios P.
    Tsirlis, Theodoros
    JOURNAL OF SURGICAL CASE REPORTS, 2024, 2024 (07):
  • [8] Renal Cell Carcinoma Metastatic to the Tongue: A Case Report and Review of the Literature
    Altuntas, Ozan
    Petekkaya, Ibrahim
    Suslu, Nilda
    Gullu, Ibrahim
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2015, 73 (06) : 1227 - 1230
  • [9] Metastatic renal cell carcinoma to the testis: A case report and review of the literature
    Marzouk, Karim
    Alyami, Fahad
    Merrimen, Jennifer
    Bagnell, Scott
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (11-12): : E924 - E927
  • [10] Metastatic Renal Cell Carcinoma to the Scalp: A Case Report With Review of Literature
    Meshikhes, Huda A.
    Khatem, Raihanah S. Al
    Albusaleh, Hassan M.
    Alzahir, Ali A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)